Early Onset Preeclampsia Is Associated With Glycocalyx Degradation and Reduced Microvascular Perfusion
Background The endothelial glycocalyx is a vasoprotective barrier between the blood and endothelium. We hypothesized that glycocalyx degradation is present in preeclampsia, a pregnancy-specific hypertensive disorder characterized by endothelial dysfunction and activation. Methods and Results We examined the sublingual glycocalyx noninvasively using sidestream dark field imaging in the third trimester among women with normotensive pregnancies (n=73), early (n=14) or late (n=29) onset preeclampsia, or gestational diabetes mellitus (n=21). We calculated the width of the glycocalyx that was permeable to red blood cells (called the perfused boundary region, a measure of glycocalyx degradation) and the percentage of vessels that were filled with red blood cells ≥50% of the time (a measure of microvascular perfusion). In addition, we measured circulating levels of glycocalyx components, including heparan sulfate proteoglycans, hyaluronic acid, and SDC1 (syndecan 1), in a subset of participants by ELISA . Repeated-measures ANOVA was performed to adjust for vessel diameter and caffeine intake. Women with early onset preeclampsia showed higher glycocalyx degradation, indicated by a larger perfused boundary region (mean: 2.14 [95% CI, 2.05-2.20]), than the remaining groups (mean: normotensive: 1.99 [95% CI, 1.95-2.02], P=0.002; late-onset preeclampsia: 2.01 [95% CI, 1.96-2.07], P=0.024; gestational diabetes mellitus: 1.97 [95% CI, 1.91-2.04], P=0.004). The percentage of vessels that were filled with red blood cells was significantly lower in early onset preeclampsia. These structural glycocalyx changes were accompanied by elevated plasma concentrations of the glycocalyx components, heparan sulfate proteoglycans and hyaluronic acid, in early onset preeclampsia compared with normotensive pregnancy. Conclusions Glycocalyx degradation and reduced microvascular perfusion are associated with endothelial dysfunction and activation and vascular injury in early onset preeclampsia.
Medienart: |
E-Artikel |
---|
Erscheinungsjahr: |
2019 |
---|---|
Erschienen: |
2019 |
Enthalten in: |
Zur Gesamtaufnahme - volume:8 |
---|---|
Enthalten in: |
Journal of the American Heart Association - 8(2019), 4 vom: 19. Feb., Seite e010647 |
Sprache: |
Englisch |
---|
Beteiligte Personen: |
Weissgerber, Tracey L [VerfasserIn] |
---|
Links: |
---|
Themen: |
Biomarkers |
---|
Anmerkungen: |
Date Completed 06.03.2020 Date Revised 09.01.2021 published: Print Citation Status MEDLINE |
---|
doi: |
10.1161/JAHA.118.010647 |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
NLM293902372 |
---|
LEADER | 01000naa a22002652 4500 | ||
---|---|---|---|
001 | NLM293902372 | ||
003 | DE-627 | ||
005 | 20231225080326.0 | ||
007 | cr uuu---uuuuu | ||
008 | 231225s2019 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.1161/JAHA.118.010647 |2 doi | |
028 | 5 | 2 | |a pubmed24n0979.xml |
035 | |a (DE-627)NLM293902372 | ||
035 | |a (NLM)30764695 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
100 | 1 | |a Weissgerber, Tracey L |e verfasserin |4 aut | |
245 | 1 | 0 | |a Early Onset Preeclampsia Is Associated With Glycocalyx Degradation and Reduced Microvascular Perfusion |
264 | 1 | |c 2019 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ƒaComputermedien |b c |2 rdamedia | ||
338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
500 | |a Date Completed 06.03.2020 | ||
500 | |a Date Revised 09.01.2021 | ||
500 | |a published: Print | ||
500 | |a Citation Status MEDLINE | ||
520 | |a Background The endothelial glycocalyx is a vasoprotective barrier between the blood and endothelium. We hypothesized that glycocalyx degradation is present in preeclampsia, a pregnancy-specific hypertensive disorder characterized by endothelial dysfunction and activation. Methods and Results We examined the sublingual glycocalyx noninvasively using sidestream dark field imaging in the third trimester among women with normotensive pregnancies (n=73), early (n=14) or late (n=29) onset preeclampsia, or gestational diabetes mellitus (n=21). We calculated the width of the glycocalyx that was permeable to red blood cells (called the perfused boundary region, a measure of glycocalyx degradation) and the percentage of vessels that were filled with red blood cells ≥50% of the time (a measure of microvascular perfusion). In addition, we measured circulating levels of glycocalyx components, including heparan sulfate proteoglycans, hyaluronic acid, and SDC1 (syndecan 1), in a subset of participants by ELISA . Repeated-measures ANOVA was performed to adjust for vessel diameter and caffeine intake. Women with early onset preeclampsia showed higher glycocalyx degradation, indicated by a larger perfused boundary region (mean: 2.14 [95% CI, 2.05-2.20]), than the remaining groups (mean: normotensive: 1.99 [95% CI, 1.95-2.02], P=0.002; late-onset preeclampsia: 2.01 [95% CI, 1.96-2.07], P=0.024; gestational diabetes mellitus: 1.97 [95% CI, 1.91-2.04], P=0.004). The percentage of vessels that were filled with red blood cells was significantly lower in early onset preeclampsia. These structural glycocalyx changes were accompanied by elevated plasma concentrations of the glycocalyx components, heparan sulfate proteoglycans and hyaluronic acid, in early onset preeclampsia compared with normotensive pregnancy. Conclusions Glycocalyx degradation and reduced microvascular perfusion are associated with endothelial dysfunction and activation and vascular injury in early onset preeclampsia | ||
650 | 4 | |a Journal Article | |
650 | 4 | |a Research Support, N.I.H., Extramural | |
650 | 4 | |a Research Support, Non-U.S. Gov't | |
650 | 4 | |a gestational diabetes mellitus | |
650 | 4 | |a microcirculation | |
650 | 4 | |a preeclampsia/pregnancy | |
650 | 4 | |a vascular glycocalyx | |
650 | 7 | |a Biomarkers |2 NLM | |
700 | 1 | |a Garcia-Valencia, Oscar |e verfasserin |4 aut | |
700 | 1 | |a Milic, Natasa M |e verfasserin |4 aut | |
700 | 1 | |a Codsi, Elizabeth |e verfasserin |4 aut | |
700 | 1 | |a Cubro, Hajrunisa |e verfasserin |4 aut | |
700 | 1 | |a Nath, Meryl C |e verfasserin |4 aut | |
700 | 1 | |a White, Wendy M |e verfasserin |4 aut | |
700 | 1 | |a Nath, Karl A |e verfasserin |4 aut | |
700 | 1 | |a Garovic, Vesna D |e verfasserin |4 aut | |
773 | 0 | 8 | |i Enthalten in |t Journal of the American Heart Association |d 2012 |g 8(2019), 4 vom: 19. Feb., Seite e010647 |w (DE-627)NLM222412712 |x 2047-9980 |7 nnns |
773 | 1 | 8 | |g volume:8 |g year:2019 |g number:4 |g day:19 |g month:02 |g pages:e010647 |
856 | 4 | 0 | |u http://dx.doi.org/10.1161/JAHA.118.010647 |3 Volltext |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_NLM | ||
951 | |a AR | ||
952 | |d 8 |j 2019 |e 4 |b 19 |c 02 |h e010647 |